Amy Xiao
Overview
Explore the profile of Amy Xiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee S, Alsamarrai A, Xiao A, Wang T
Intern Med J
. 2024 Jun;
54(8):1254-1263.
PMID: 38874281
Cancer therapy-related cardiac dysfunction (CTRCD) is a complication of selected cancer therapy agents associated with decline in left ventricular ejection fraction (LVEF). Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers...
2.
Wu M, Hanly A, Gibson F, Fisher R, Rogers S, Park K, et al.
J Clin Invest
. 2024 Feb;
134(6).
PMID: 38300709
Virtually all patients with BRAF-mutant melanoma develop resistance to MAPK inhibitors largely through nonmutational events. Although the epigenetic landscape is shown to be altered in therapy-resistant melanomas and other cancers,...
3.
CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule
Xiao A, Beatty C, Choudhary S, Akilov O
Hematol Rep
. 2023 Sep;
15(3):513-517.
PMID: 37754668
Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), is a rare and aggressive variant of primary cutaneous lymphoma that typically expresses B cells as well as MUM1/IRF4, BCL2, and...
4.
Xiao A, Falcone L, English Iii J
Case Rep Dermatol Med
. 2023 Feb;
2023:7751754.
PMID: 36733915
While most forms of sarcoidosis of the skin do not require treatment, 40% of patients initially diagnosed with cutaneous sarcoidosis are found to have an asymptomatic disease involving other organ...
5.
Armas F, Chandra F, Lee W, Gu X, Chen H, Xiao A, et al.
Environ Int
. 2022 Dec;
171:107718.
PMID: 36584425
SARS-CoV-2 wastewater-based surveillance (WBS) offers a tool for cost-effective oversight of a population's infections. In the past two years, WBS has proven to be crucial for managing the pandemic across...
6.
Xiao A, Akilov O
Cells
. 2022 Nov;
11(22).
PMID: 36429020
The loss of CD47 on aging cells serves as a signal to macrophages to eliminate the target. Therefore, CD47 is a "do-not-eat-me" sign preventing macrophagal phagocytosis via interaction with its...
7.
Xiao A, Miedler J, Akilov O
JAAD Case Rep
. 2022 Nov;
30:38-40.
PMID: 36386059
No abstract available.
8.
Duvallet C, Wu F, McElroy K, Imakaev M, Endo N, Xiao A, et al.
ACS ES T Water
. 2022 Nov;
2(11):1899-1909.
PMID: 36380771
Wastewater-based epidemiology has emerged as a promising technology for population-level surveillance of COVID-19. In this study, we present results of a large nationwide SARS-CoV-2 wastewater monitoring system in the United...
9.
Phan T, Brozak S, Pell B, Gitter A, Xiao A, Mena K, et al.
Sci Total Environ
. 2022 Oct;
857(Pt 1):159326.
PMID: 36220466
Wastewater-based surveillance (WBS) has been widely used as a public health tool to monitor SARS-CoV-2 transmission. However, epidemiological inference from WBS data remains understudied and limits its application. In this...
10.
DAoust P, Tian X, Towhid S, Xiao A, Mercier E, Hegazy N, et al.
Sci Total Environ
. 2022 Sep;
853:158547.
PMID: 36067855
Clinical testing has been the cornerstone of public health monitoring and infection control efforts in communities throughout the COVID-19 pandemic. With the anticipated reduction of clinical testing as the disease...